Literature DB >> 11186882

Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study.

E L Gould1, D Z Loesch, M J Martin, R J Hagerman, S M Armstrong, R M Huggins.   

Abstract

Sleep patterns and endogenous melatonin profiles in 13 fragile X boys between the age of 4.7 and 11.0 years were compared to those of 8 age-matched, normal control boys. Parents recorded sleep patterns on a Sleep Diary Chart for 14 consecutive days. Twelve saliva samples were obtained from 8 fragile X participants and all of the controls over 48 hours for the assessment of salivary melatonin profiles. The results showed greater variability in total sleep time and difficulty in sleep maintenance in fragile X boys compared with the control participants. Nocturnal melatonin production, expressed as both peak level and area under the concentration-time curve between 20:00 h and 08:00 h, were found to be significantly larger in fragile X boys than in controls. Additionally, the mean of the minimum daytime melatonin levels recorded was significantly higher for the fragile X group. Elevated levels in some fragile X boys relative to the range seen in controls, occurring either during the day or at night, or in both segments of the secretory profile for some individuals, may be due in part to overactivity of the sympathetic nervous system. Alternative molecular mechanisms leading to changes in melatonin profiles in fragile X are also discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11186882

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  28 in total

Review 1.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

2.  Comprehensive motor testing in Fmr1-KO mice exposes temporal defects in oromotor coordination.

Authors:  Snigdha Roy; Yu Zhao; Melody Allensworth; Mohamed F Farook; Mark S LeDoux; Lawrence T Reiter; Detlef H Heck
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

Review 3.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

4.  Sleep in Neurodevelopmental Disorders.

Authors:  Anna J Esbensen; Amy J Schwichtenberg
Journal:  Int Rev Res Dev Disabil       Date:  2016

5.  The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.

Authors:  Juthamas Wirojanan; Sebastien Jacquemont; Rafael Diaz; Susan Bacalman; Thomas F Anders; Randi J Hagerman; Beth L Goodlin-Jones
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

6.  Fragile X-related proteins regulate mammalian circadian behavioral rhythms.

Authors:  Jing Zhang; Zhe Fang; Corinne Jud; Mariska J Vansteensel; Krista Kaasik; Cheng Chi Lee; Urs Albrecht; Filippo Tamanini; Johanna H Meijer; Ben A Oostra; David L Nelson
Journal:  Am J Hum Genet       Date:  2008-06-26       Impact factor: 11.025

7.  Casein kinase II phosphorylates the fragile X mental retardation protein and modulates its biological properties.

Authors:  Mikiko C Siomi; Kyoko Higashijima; Akira Ishizuka; Haruhiko Siomi
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

8.  Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Development       Date:  2008-06-25       Impact factor: 6.868

Review 9.  Fragile X syndrome: A review of clinical management.

Authors:  Reymundo Lozano; Atoosa Azarang; Tanaporn Wilaisakditipakorn; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

10.  Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Neural Circuits       Date:  2009-08-20       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.